DAFTAR PUSTAKA

1. Lebon A, Labout JAM, Verbrugh HA, et al. Role of Staphylococcus aureus nasal colonization in atopic dermatitis in infants. Arch Pediatr Adolesc Med 2009; 163(8):745-749. 2. Profil Kesehatan Indonesia 2009. Jakarta: Kementrian Kesehatan Republik Indonesia, 2010. 3. Perlroth J, Kuo M, Tan J, et al. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections. Arch Intern Med 2008; 168(8): 805-819. 4. Stevens DL, Bisno AL, Chambers HF, et al. Practice guideline for the diagnosis and management of skin and soft-tissue infections. CID 2005; 41: 1373-1406. 5. Nicolle LE. Infection control programmes to contain antimicrobial resistance. World Health Organizations 2001; 7: 1-53. 6. Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch of Med Research 2005; 36: 697-705. 7. WHO global strategy for containment of Switzerland: World Health Organization, 2001. antimicrobial resistance.

8. Joo H, Chan JL, Cheung GYC, et al. Subinhibitory concentration of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphyloccous aureus. Antimicrob Agents Chemother 2010; 54(11): 4942-4944. 9. Dumitresu O, Choudhury P, Boisset S, et al. -lactams interfering with PBP1 induce panton-valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55(7): 3261-3271. 10. Staf Pengajar FK UI. Mikrobiologi kedokteran. Jakarta: Binarupa Aksara, 1994. 11. Noskin GA, Rubin RJ, Schentag JJ, et al. The burden of Staphylococcus aureus infections on hospitals in the United States. Arch Intern Med 2005; 165: 1756-1761. 12. Brooks GF, Butel JS, Morse SA. Jawetz, Melnicks, and Adelbergs medical microbiology. 23rd ed. New York: Lange Medical Books, 2004.

13. Refdanita, Maksum R, Nurgani A, et al. Pola kepekaan kuman terhadap antibiotik di ruang rawat intensif Rumah Sakit Fatmawati Jakarta tahun 20012002. Makara, 2004; 8: 41-48. 14. Ridhayanti N. Pola resistensi isolat Staphylococcus aureus dari berbagai bahan pemeriksaan klinik terhadap antibiotik terpilih in vitro. KTI. Banjarbaru: FK UNLAM, 2011. 15. Vree TB, Dammers E, Exler PS. Identical pattern of highly variable absorption of clavulanic acid from four different oral formulations of coamoxiclav in healthy subjects. JAC 2003; 51: 373-378. 16. Beceiro A, Lpez-Rojas R, Domnguez-Herrera J, et al. In vitro activity and in vitro efficacy of clavulanic acid against Acinetobacter baumannii. Antimicrob Agents Chemother 2009; 53(10): 4298-4304. 17. Koeth LM, Good CE, Appelbaum PC, et al. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to coamoxiclav and five other antimicrobial agents. JAC 2004; 53: 1039-1044. 18. White AR, Kaye C, Poupard J, et al. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. JAC 2004: 53; i3-i20. 19. Landersdorfer CB, Kinzig M, Bulitta JB, et al. Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation. Antimicrob. Agents Chemother 2009; 53 (6): 25692578. 20. Siibak T, Peil L, Xiong L, et al. Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition. Antimicrob. Agents Chemother 2009; 53 (2): 563-571. 21. Chen Y, Deng W, Wu J. et al. Genetic modulation of the overexpression of tailoring genes eryK dan eryG leading to the improvement of erythromycin A purity and production in Saccharopolyspora erythraea fermentation. Appl Environ Microbio 2008; 74 (6): 1820-1828. 22. Katzung BG. Farmakologi dasar dan klinik buku 3 edisi 8. Jakarta: Salemba Medika, 2004. 23. Henry F. Antimicrobial agents: general considerations. In: Goodman AG, Hardman JG, Limbird LE. Goodman & Gillmans the pharmacological basis of therapeutics. 10th ed. New York: McGraw Hill, 2001.

24. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. The American Journal of Medicine 2006; 119 (6A): S3-S10. 25. Fiebelkorn KR, Crawford SA, McElmeel ML, et al. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41: 4740-4744. 26. Mesak LR, Miao V, Davies J. Effects of subinhibitory concentration of antibiotics on SOS and DNA repair gen expression in Staphylococcus aureus. Antimicrob Agents Chemother. 2008; 52(9): 3394-3397. 27. Pompilio A, Catavitello C. Picciani C, et al. Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis. Journal of Medical Microbiology 2010; 59: 76-81. 28. Wahjono H. Penggunaan antibiotik secara rasional pada penyakit infeksi. Medika 2002; 2: 42-47. 29. Daka D, Silassie SG, Yihdego D. Antibiotic-resistance Staphyloccocus aureus isolated from cows milk in Hawassa area, South Ethiopia. African Journal of Microbiology Research 2012; 6 (27): 5618-5624. 30. Niebuhr M, Mai U, Kapp A, et al. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. Exp Dermatol 2008; 17 (11): 953-957. 31. Qu F, Cui E, Guo T, et al. Nasal colonization of clonal transmission of methicillin-susceptible Staphulococcus aureus among Chinese military volunteers. J Clin Microbiol 2010; 48(1): 64-69. 32. Sahoo KC, Tamhankar AJ, Johansson E, et al. Antibiotic use, resistance development and enviromental factors: a qualitative study among healthcare professionals in Orissa, India. BMC Public Health 2010; 10: 629. 33. Nielsen LN, Roggenbuck M, Haaber J, et al. Diverse modulation of spa transcription by cell wall active antibiotics in Staphylococcus aureus. BMC Research Notes 2012; 5: 457. 34. Rasigade JP, Moulay A, Lhostel Y, et al. Impact of sub-inhibitory antibiotics on fibronectin-mediated host cell adhesion and invasion by Staphylococcus aureus. BMC Microbiology 2011; 11: 263.

35. Yoshizawa S, Tateda K, Saga T, et al. Virulence-suppresing effects of linezolid on methicillin-resistant staphylococcus aureus: possible contribution to early defervescence. Antimicrob. Agents Chemother 2012; 56(4): 1744.